#NEWS : Data from a Phase 2b study for a novel investigational oral BTK inhibitor for the treatment of asthma were presented at #ATS2024 . Learn more 👇

Experience the next chapter in our journey to becoming the first biopharma company powered by AI at scale this week at #VivaTech

Learn more about our innovations: spkl.io/601744l6h

📍 Join us on Stand J24 to meet our experts and discover the next generation of healthcare

Less than 24H until #VivaTech ! Join us this year to discover the next steps in our journey to becoming the first biopharma powered by #AI at scale.

Join us on Stand J24 to meet our experts.
📍Stand J24
🧬 6 Interactive Experiences
🗣️ 38 Expert Speakers

Today, hours from the opening of #VivaTech , we’re excited to announce our collaboration with @FormationBio & OpenAI to build first-in-class AI-powered software. Join us at VivaTech for more on our AI innovations. ⤵️

#NEWS : Late-breaking data from our replicate Phase 3 trial in COPD were presented at #ATS2024 and published in NEJM. Explore the latest results for this complex respiratory disease. Regeneron ⬇️

Read our press release: spkl.io/601144bCN

To mark the 100 days to the Paris 2024 Paralympic Games the #MeningitisFlag is spreading its colors across the French capital! Sport goes beyond medals; it ignites change beyond its realms. If only it could help change #meningitis awareness. AI-Generated images by IfOnlyAI
Meningitis Research

AI is a powerful tool, but it’s our role as innovators to be accountable to its outcomes. We believe this goes beyond legal compliance and uphold our Responsible AI Standards from design through to use. Read more: sanofi.com/en/magazine/ou…

Who pushes you to go for gold? 🥇 For #TeamSanofi athlete Amandine Buchard OLY, it’s her best friend Julia.

Watch to learn more about Amandine’s story of resilience as she takes on the Olympic Games #Paris2024 💪

#IgnitingPotential #WeNeverSettle

The Olympic Flame just passed through our R&D site in Montpellier, France! 🔥

The journey is not over, the relay goes on with lots of key stops coming up. Stay tuned ✨

#IgnitingPotential #Paris2024 Paris 2024

Yesterday, 4 Sanofians carried the Olympic Torch in Ville de Marseille, France 🇫🇷

Over the next few weeks, the Torch will travel to several Sanofi sites across France, with nearly 300 Sanofians participating as official Torchbearers. Stay tuned! 🔥

#IgnitingPotential #Paris2024

Watching the Olympic torch arrive from Greece was such an inspiring moment for our Sanofians 🔥

We're excited to continue the torch relay tomorrow in Ville de Marseille for this once in a lifetime event.

#Paris2024 #IgnitingPotential

.The Lancet has recently published new data from Galicia, Spain, showing real-world impact on respiratory syncytial virus ( #RSV ) hospitalizations in infants after the introduction of our #immunization .

At #ATS2024 we’re presenting 25 abstracts across respiratory diseases, including #COPD and #asthma . We’re committed to further understanding patient needs in these complex conditions. Learn more ⬇️

bit.ly/3xLx9Jh

Our CEO Paul Hudson reflects on our strong start of the year, driven by launches and the transformation of our portfolio of medicines and vaccines.

Learn more about our first quarter 2024 results: spkl.io/601542oaR

#SanofiResults $SAN $SNY

Our first quarter 2024 results are now available. Read the press release: sanofi.com/en/investors/f…

#SanofiResults  $SAN $SNY

Who inspires you to push the limits? For Youxin, senior scientist and volunteer for the #Olympic Games #Paris2024 , it’s her mentor Alexey. 💫 #IgnitingPotential #WeNeverSettle

#NEWS : Positive Phase 3 data demonstrate the potential of a new first-in-class treatment for immune thrombocytopenia ( #ITP ). Learn more about the results and how we’re committed to transforming the standard of care for people with ITP: sanofi.com/en/media-room/…

Sometimes we need someone who believes in us more than we believe in ourselves. 🔥

For #TeamSanofi athlete Ezra Frech, the person who ignites his potential 24/7 is his mum.

Find out more about his story 👇

#IgnitingPotential #Paris2024

NEWS: We chase the latest science to address unmet needs facing the #MultipleSclerosis community. Our new data at #AAN for our investigational anti-CD40L illustrates our progress. ⤵️ sanofi.com/en/media-room/…